Below you find the most important publications.
 
1. Lachmann R and Brückmann A.
Comment on: Absent ‘superimposed line’ sign: a novel marker in early diagnosis of secondary cleft palate by Lakshmy S et al
Ultrasound Obstet Gynecol 2020 - accepted
5 Jahres Impact Faktor: 3.56-5.65
 
2. Fietz SA, Namba T, Kirsten H, Huttner WB, Lachmann R.
Signs of reduced basal progenitor levels and cortical neurogenesis in human foetuses with open spina bifida at 11-15 weeks of gestation
Journal Neurosci 2020, 0192-19; DOI: 10.1523/JNEUROSCI.0192-19.2019

5 Jahres Impact Faktor 6.07-6.34

 

3. Lachmann R. [Letter-To-The-Editor]
Comment on the paper: A prospective study on fetal posterior cranial fossa assessment for early detection of open spina bifida at 11–13 weeks. Congenital Anomalies 2017 doi: 10.1111/cga.12265 [Epub ahead of print]
5 Jahres Impact Faktor: 1.16-1.58

 

4. Lachmann R, Schilling U, Brückmann D, Weichert A, Brückmann A. Isolated Cleft Lip and Palate: Maxillary Gap Sign and Palatino-Maxillary Diameter at 11-13 Weeks.
Fetal Diagn Ther. 2017 Oct 26. doi: 10.1159/000481773. [Epub ahead of print]
5 Jahres Impact Faktor: 1.90-2.70


5. Lachmann R, Sinkovskaya E, Abuhamad A.
Posterior brain in fetuses with Dandy-Walker malformation with complete agenesis of the cerebellar vermis at 11-13 weeks: a pilot study.
Prenat Diagn. 2012 Aug;32(8):765-9.
5 Jahres Impact Faktor: 2.10-3.04


6. Lachmann R, Picciarelli G, Moratalla J, Greene N, Nicolaides KH.
Fronto-Maxillary facial angle in fetuses with spina bifida at 11-13 weeks' gestation.
Ultrasound Obstet Gynecol. 2010; 36:268-271
5 Jahres Impact Faktor: 3.56-5.65


7. Lachmann R, Sodre D, Barmpas M, Akolekar R, Nicolaides KH.
Midbrain and falx in fetuses with absent corpus callosum at 11-13 weeks. Fetal Diagn Ther. 2013;33(1):41-6.
5 Jahres Impact Faktor: 1.90-2.70


8. Lachmann R, Chaoui R, Moratalla J, Picciarelli G, Nicolaides KH.
Posterior brain in fetuses with open spina bifida at 11 to 13 weeks.
Prenat Diagn. 2011 Jan;31(1):103-6.
5 Jahres Impact Faktor: 2.10-3.04


9. Lachmann R. [Letter-To-The-Editor]
Correspondence regarding research letter published by Arigita et al.
Prenat Diagn. 2012 Feb;32(2):201; author reply 202-3.
5 Jahres Impact Faktor: 2.10-3.04


10. Ramsauer B, Duwe W, Schlehe B, Pitts R, Wagner D, Wutkewicz K, Chuvashkin D,Abele H, Lachmann R.
Effect of blood on ROM diagnosis accuracy of PAMG-1 and IGFBP-1 detecting rapid tests.
J Perinat Med. 2015 Jul;43(4):417-22.
5 Jahres Impact Faktor: 1.58-1.95


11. Hofmann SR, Heilmann A, Häusler HJ, Dähnert I, Kamin G, Lachmann R. Congenital idiopathic dilatation of the right atrium: antenatal appearance, postnatal management, long-term follow-up and possible pathomechanism. Fetal Diagn Ther. 2012;32(4):256-61.
5 Jahres Impact Faktor: 1.90-2.70


12. Lachmann R, Kamin G, Kamil D, VanDeVondel P, Staboulidou I, Distler W
B-Lynch-Naht–Technik und Vergleich mit der bimanuellem Uteruskompression.
Der Gynäkologe (2008) 41: 123. 10.1007/s00129-007-2104-6
5 Jahres Impact Faktor: n/a


13. Lachmann R, Kamin G, Bender F, Jaekel M, Distler, W. (2008). Fruchtwasserembolie – Übersicht und Falldarstellung mit gutem Outcome.
Der Gynäkologe. 41. 10.1007/s00129-008-2136-6.
5 Jahres Impact Faktor: n/a


14. Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH.
Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.
Ultrasound Obstet Gynecol. 2010 Jun;35(6):662-70.
5 Jahres Impact Faktor: 3.56-5.65


15. Florio M, Albert M, Taverna E, Namba T, Brandl H, Lewitus E, Haffner C, Sykes A, Wong FK, Peters J, Guhr E, Klemroth S, Prüfer K, Kelso J, Naumann R, Nüsslein I, Dahl A, Lachmann R, Pääbo S, Huttner WB. Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion.
Science. 2015 Mar 27;347(6229):1465-70.
5 Jahres Impact Faktor: 31.0-37.2


16. Lachmann R.
Das Konzept “Turning the Pyramid of Care” – Neues erweitertes Ersttrimesterscreening; 2014. Fortbildung/Übersichtsartikel gynäkologie+geburtshilfe 2014 (19) 5; 29-32
5 Jahres Impact Faktor: n/a


17. Lachmann R, Schlembach D.
Präeklampsiescreening - Prädiktion und Prävention im 1., 2. und 3. Trimenon. Review. Frauenarzt 54 (2013), 323-331
5 Jahres Impact Faktor: n/a


18. Lachmann R.
Frühgeburt – Einfluss auf Screening, Prävention und geburtshilfliche Risiken der Konisation mit 12, 20 und 30 Schwangerschaftswochen.
gyn (20) 2015; 1-9
5 Jahres Impact Faktor: n/a


19. Lachmann R, Schleussner E.
Frühgeburt - Prädiktion, Prävention und Diagnostik.
gynäkologie+geburtshilfe 2013 (18) 4; 32-38
5 Jahres Impact Faktor: n/a


20. Lachmann R.
Frühgeburtsscreening, -prävention und geburtshilfliche Risiken der Konisation.
gyn (18) 2013; 1-8
5 Jahres Impact Faktor: n/a


21. Scheier M, Lachmann R, Pětroš M, Nicolaides KH.
Three-dimensional sonography of the posterior fossa in fetuses with open spina bifida at 11-13 weeks' gestation.
Ultrasound Obstet Gynecol. 2011 Dec;38(6):625-9.
5 Jahres Impact Faktor: 3.56-4.71


22. Berg C, Lachmann R, Kaiser C, Kozlowski P, Stressig R, Schneider M, Asfour B, Herberg U, Breuer J, Gembruch U, Geipel A.
Prenatal diagnosis of tricuspid atresia: intrauterine course and outcome. Ultrasound Obstet Gynecol. 2010 Feb;35(2):183-90.
5 Jahres Impact Faktor: 3.56-4.71


23. Moratalla J, Pintoffl K, Minekawa R, Lachmann R, Wright D, Nicolaides KH.
Semi-automated system for measurement of nuchal translucency thickness.
Ultrasound Obstet Gynecol. 2010 Oct;36(4):412-6.
5 Jahres Impact Faktor: 3.56-5.65


24. Ball S, Wright D, Sodre D, Lachmann R, Nicolaides KH.
Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidies.
Fetal Diagn Ther. 2012;31(3):162-9.
5 Jahres Impact Faktor: 1.90-2.70


25. Lato K, Gembruch U, Geipel A, Lachmann R, Schneider M, Hraska V, Berg C.
Tricuspid atresia with absent pulmonary valve and intact ventricular septum: intrauterine course and outcome of an unusual congenital heart defect.
Ultrasound Obstet Gynecol. 2010 Feb;35(2):243-5.
5 Jahres Impact Faktor: 3.56-4.71


26. Camp JG, Badsha F, Florio M, Kanton S, Gerber T, Wilsch-Bräuninger M, Lewitus E, Sykes A, Hevers W, Lancaster M, Knoblich JA, Lachmann R, Pääbo S, Huttner WB, Treutlein B.
Human cerebral organoids recapitulate gene expression programs of fetal neocortex development.
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):15672-7.
5 Jahres Impact Faktor: 9.42-9.81


27. Mora-Bermúdez F, Badsha F, Kanton S, Camp JG, Vernot B, Köhler K, Voigt B, Okita K, Maricic T, He Z, Lachmann R, Pääbo S, Treutlein B, Huttner WB.
Differences and similarities between human and chimpanzee neural progenitors during cerebral cortex development. Elife. 2016 Sep 26;5.
5 Jahres Impact Faktor: 7.73-8.52


28. Fietz SA, Lachmann R, Brandl H, Kircher M, Samusik N, Schröder R,
Lakshmanaperumal N, Henry I, Vogt J, Riehn A, Distler W, Nitsch R, Enard W, Pääbo S, Huttner WB.
Transcriptomes of germinal zones of human and mouse fetal neocortex suggest a role of extracellular matrix in progenitor self-renewal.
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11836-41.
5 Jahres Impact Faktor: 9.42-9.81


29. Schleussner E, Kamin G, Seliger G, Rogenhofer N, Ebner S, Toth B, Schenk M, Henes M, Bohlmann MK, Fischer T, Brosteanu O, Bauersachs R, Petroff D; ETHIG II group.
Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
Ann Intern Med. 2015 May 5;162(9):601-9.
5 Jahres Impact Faktor: 13.98-17.81


30. Wimberger P, Chebouti I, Kasimir-Bauer S, Lachmann R, Kuhlisch E, Kimmig R, Süleyman E, Kuhlmann JD.
Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Gynecol Oncol. 2014 Jun;133(3):467-72.
5 Jahres Impact Faktor: 3.69-4.96

Druckversion Druckversion | Sitemap
© Fetal Medicine Centre Germany / Dr. Robert Lachmann